In This Issue

Accreditation Statistics

As of August 1, 2023

Cellular Therapy Entities

  • Accredited: 255
  • Applicants: 26

Cord Blood Banks

  • Accredited: 53
  • Applicants: 9

Congratulations to the following organizations for achieving initial accreditation:

Pennsylvania Hospital, Penn Medicine: Adult autologous hematopoietic progenitor cellular therapy, peripheral blood cellular therapy product collection, and cellular therapy product processing with minimal manipulation

Sarah Cannon Transplant & Cellular Therapy Program at MountainView Hospital: Adult autologous hematopoietic progenitor cellular therapy, immune effector cellular therapy administration, peripheral blood cellular therapy product collection, and cellular therapy product processing with minimal manipulation

A complete list of accredited organizations can be found at www.factglobal.org.

ISCT Initiatives Address both Workforce Challenges and Regulatory Knowledge

Posted in :: 2023 Volume 4 :: Thursday, July 27th, 2023

ISCT has announced the following initiatives related to workforce development and regulations. Follow the links for more information and take advantage of these opportunities!

  • Cell and Gene Therapy Global Regulatory Report: The first biannual global regulatory report from ISCT and Citeline includes a global overview of the cell and gene therapy landscape, regulatory events, and key legislative/framework changes and international standards.
  • In-person Technologist Training Course at the ISCT NA 2023 Regional Meeting in Houston: This course is designed by experts to provide essential skills and knowledge for CGT manufacturing. The one-day interactive course on September 10 in Houston at the North America Regional Meeting will cover essential topics such as collections, QC/QA, regulatory, distribution logistics, and devices, and will provide insights into working with industry partners.
  • ISCT Workforce Development in Biomanufacturing Advanced Hands-On Training Course: This five-day, hands-on training teaches you the techniques central to cell and gene therapy manufacturing, including aseptic cell culture techniques, large-scale cell manufacturing, analytical techniques and product characterization, cell banking and documentation using GLP/GMP-like best practices. It will take place August 7 – 11, 2023 at Georgia Institute of Technology in Atlanta.
  • 2023 Global Workforce Development Survey: The 2023 survey aims to collect information about historic and recurring training opportunities pursued by respondents, as well as information about current roles and responsibilities. The survey also aims to gather insights into the current state of the CGT field in order for ISCT to identify gaps in training and education to develop strategies to address them effectively. The survey should take approximately 10 minutes, and results will be publicly available in a report published by ISCT once data has been analyzed. All participant data will be anonymized. The survey closes August 8, 2023.